media - CAS号查询

1,3-Bisbenzyl-2-oxoimidazolidine-4,5-dicarboxylic acid;
1,3-DIBENZYL IMIDAZOLIDINONE-4,5-DICARBOXYLIC ACID;
1,3-BISBENZYL-2-OXOIMIDAZOLIDINE-4,5-DICARBOXYLIC ACID;
1,3-Dibenzyl-2-Imidaxzolidone-Cis-4,5-Dicarboxylic Acid;
Vitamin H intermediates Cyclic acid;
1,3-BISBENZYL-2-OXOIMIDAZOLIDINE-4,5-DI&;
CYCLIC ACID;
1,3-Dibenzyl-2-imidax zolidone-cis-4,5-dicarboxylic

C19H18N2O5

详情

供应商

99464-83-2

1-氯乙基环己基碳酸酯

1-Chloroethyl cyclohexyl carbonate;
1-Chloroethyl Cyclohexyl Carbonate (Intermediate of Candesartan Cilexetil);
1-Chloro Ethyl Cyclohexyl Carbonate;
1-ChloroethylCyclohexylCarbonate;
Cyclohexyl-(1-chloroethyl)-carbonate;
1-Chloroethyl Cyclohexyl Carbonate (JCC-2);
Intermediate of Candesartan Cilexetil;

6-氟-7-哌嗪-1-甲基-4-氧代-[1,3]硫氮杂环[3,2-a]喹啉-3-羧酸乙酯

Ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piprazinyl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate;
ethyl 6-fluoro-1-methyl-4-oxo-7-(1-piprazinyl)-4h-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate;
6-FLUORO-1-METHYL-4-OXO-7(1-PIPERAZINYL)-4H-(1,3)THIAZETO(3,2-A)QUINOLINE-3-CARBOYLIC ACID ETHYL ESTER;
PRULIFLOXACIN INTERmediaTE 2;
ETHYL 6-FLUORO-1-METHYL-4-OXO-7-(1-PIPRAZINYL)-4H-(1,3)THIAZETO(3,2-A)QUINOLINE-;
Ethyl 6-Fluoro-1-Methyl-4-Oxo-7-91-Piperazinyl)-4h-(1,3-)-Thiazeto-(3,2-A)Quinoline-3-Carboxylate;
6-FLUORO-1-METHYL-4-OXO-7-(1-PIPERAZINYL)-4H-(1,3)THIAZETO(3,2-A)QUINOLINE-3-CARBOYLIC ACID ETHYL ESTER;
6-FLUORO-1-METHYL-4-OXO-7-(1-PIPRAZINYL)-1H,4H-(1,3)THIAZETO(3,2-A)QUINOLINE-3-CARBOXYLIC ACID, ETHYL ESTER;
6-Fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-1H,4H-[1,3]-thiazeto[3,2-a]-3-quinolinecarboxylic acid ethyl ester

6,7-二氟-1-甲基-4-氧代-4H-[1,3]噻嗪[3,2-a]并喹啉-3-羧酸乙酯

Ethyl 6,7-difluoro-1-methyl-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate;
PRULIFLOXACIN INTERmediaTE 1;
6,7-DIFLUORO-1-METHYL-4-OXO-4H-[1,3]THIAZETO[3,2-A]-3-QUINOLINE CARBOXYLIC ACID ETHYL ESTER;
6,7-DIFLUORO-1-METHYL-4-OXO-4H-(1,3)THIAZETO(3,2-A)QUINOLINE-3-CARBOYLIC ACID ETHYL ESTER;
6,7-DIFLUORO-1-METHYL-4-OXO-4H-2-THIA-8B-AZA-CYCLOBUTA[A]NAPHTHALENE-3-CARBOXYLIC ACID ETHYL ESTER;
ETHYL 6,7-DIFLUORO-1-METHYL-4-OXO-4H-[1,3]THIAZETO[3,2-A]QUINOLINE-3-CARBOXYLATE;
Ethyl 6,7-Difluoro-1-Methyl-4-Oxo-1H,4H-(1,3)Thiazeto(3,2-a)Quinoline-3-Carboxylate;
ETHYL 6,7-DIFLUORO-1-METHYL-4-OXO-4H-(1,3-)THIAZETO(3,2,-A)QUINOLINE-3-CARBOXYLA;
PRULIFLOXACIN INTERmediaTE

多西紫杉醇中间体;
多西他赛中间体

Docetaxel intermediate;
(aR,bS)-beta-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-hydroxy-benzenepropanoic acid (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2,2-trichloroethoxy)carbonyl]oxy]-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester

3-氯-4-[1,1,2-三氟-2-(三氟甲氧基)乙氧基]苯胺

3-Chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]benzenamine;
NOVALURON INTERmediaTE;
3-CHLORO-4-[1,1,2-TRIFLUORO-2-(TRIFLUOROMETHOXY)ETHOXY]BENZENAMINE;
4-trifluoromethoxy trifluoroethoxy-5-chloroaniline

4-[4-(N-哌啶甲基)吡啶-2-氧]顺-2-丁烯-1-胺

4-[4-(Piperidinomethyl)pyridyl-2-oxy]-cis-2-butenamine;
4-(4-PIPERIDIN-1-YL-METHYL-PYRIDIN-2-YL-OXY)-BUT-2-ENYLAMINE;
4-[4-(PIPERIDINOMETHYL)PYRIDYL-2-OXY]-CIS-2-BUTENAMINE;
4-[4-(PIPERIDINOMETHYL)PYRIDYL-2-OXY]-CIS-2-BUTENAMINE(INTERmediaTE FOR LAFUTIDINE);
4-[4-(Piperidinomethyl)pyridyl;
4-[4-(PIPERIDINOMETHYL)PYRIDYL-2-OXY]-CIS-2-BUTENAMINE(PREPARATION FOR LAFUTIDINE);
4(E)-4-(4-(PIPERIDIN-1-YLMETHYL)PYRIDIN-2-YLOXY)BUT-2-EN-1-AMINE (INTERmediaTE FOR LAFUTIDINE)

2',2'-二氟-2'-脱氧胞嘧啶核苷-3',5'-二苯甲酸酯

2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate;
2,2-Difluoro-2-deoxycytidine-3,5-dibenzoate;
2?Deoxy-2?2?difluro-3??bis-O-benzoylcytidine;
2-deoxy-2’,2’-difluoro-3’5’-bis-o-benzoyleytidine monohydrochloride;
2,2-Difluoro-2-deoxycyodine-3,5-dibenzoate(or its salt);
2’,2’-Difluoro-2’-deoxycyodine-3’,5’-dibenzoate;
2',2'-difluoro-2'-deoxycyldine-3',5'-dibenzoate;
2',2'-Difluoro-3',5'-dibenzoyl-2'-deoxycytidine;
3',5'-Di-O-benzoyl-2',2'-difluoro-2'-deoxy cytidine;
2'2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate;
2',2'-Difluoro-3',5'--dibenzoyl-2'-deoxycytidine;
Gemcitabine HCl Intermediate T9;

N-[顺-4-[4-(N-哌啶甲基)吡啶-2-氧]-2-丁烯-1-基]邻苯二甲酰亚胺顺丁烯二酸盐

N-{4-[4-(Piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide maleic acid;
n-[4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene]phthalimide maleic acid;
n-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide maleate;
n-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide maleic acid(intermediate for lafutidine);
n-phthalimide maleic acid;
n-{4-[4-(piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}

泰利霉素中间体5A

3-De[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-10,11-didehydro-11-deoxy-6-O-met;
3-de[(2,6-dideoxy-3-c-methyl-3-o-methyl-a-l-ribo-hexopyranosyl)oxy]-10,11-didehydro-11-deoxy-6-o-methyl-3-oxo-erythromycin 2’-acetate;
Telithromycin intermediate (6A);
2 ∧ -OBEZOYL -3-O-DE [(2, 6-DIDEOXY-3-C-METHYL-3-O-METHYL-α-L-RIBOHEXOPYRANOSYL)OXY]-11-DEOXY-10,11-DIDEHYDRO-6-O-METHYL-3-OXO ERYTHROMYCIN;
2’-OBEZOYL-3-O-DE[(2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-ALPHA-L-RIBOHEXOPYRANOSYL)OXY]-11-DEOXY-10,11-DIDEHYDRO-6-O-METHYL-3-OXO-ERYTHROMYCIN;
3-DE[(2,6-DIDEOXY-3-C-METHYL-3-O-METHYL-A-L-RIBO-HEXOPYRANOSYL)OXY]-10,11-DIDEHYDRO-11-DEOXY-6-O-METHYL-3-OXO-ERYTHROMYCIN 2’-ACETATE;
2 ’’-OBEZOYL -3-O-DE [(2, 6-DIDEOXY-3-C-METHYL-3-O-METHYL-A-L-RIBOHEXOPYRANOSYL)OXY]-11-DEOXY-10,11-DIDEHYDRO-6-O-METHYL-3-OXO ERYTHROMYCIN

泰利霉素中间体(7A)

Telithromycin intermediate (7A);
2'-Obezoyl-3-O-de[(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribohexopyranosyl)oxy]-11-deoxy-10,11-didehydro-12-O-[(1H-imidazol-1-yl)carbonyl]-6-O-methyl-3-oxo-erythromycin

尼罗替尼;
4-甲基-3-((4-(3-吡啶基)-2-嘧啶基)氨基)-N-(5-(4-甲基-1H-咪唑-1-基)-3-(三氟甲基)苯基)苯甲酰胺

Nilotinib;
Nilotinib & its intermediates

Benzenesulfonic acid,dodecyl-, strontium salt (8CI,9CI);
RetzloffIntermediate No. 3;
Strontium dodecylbenzene sulfonate

Corticotropin-likeintermediate lobe peptide B (Xenopus laevis) (9CI);
a18-39-Corticotropin (pig),20-L-isoleucine-27-L-valine-29-L-glutamicacid-31-L-serine-34-L-serine-37-L-methionine-39-L-leucine-;
L-Leucine,L-arginyl-L-prolyl-L-leucyl-L-lysyl-L-valyl-L-tyrosyl-L-prolyl-L-asparaginylglycyl-L-valyl-L-a-glutamyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-alanyl-L-a-glutamyl-L-seryl-L-phenylalanyl-L-prolyl-L-methionyl-L-a-glutamyl-

Corticotropin-likeintermediate lobe peptide A (Xenopus laevis) (9CI);
a18-39-Corticotropin (pig),20-L-isoleucine-27-L-valine-29-L-glutamicacid-31-L-serine-34-L-serine-35-L-tyrosine-37-L-methionine-39-L-leucine-;
L-Leucine,L-arginyl-L-prolyl-L-isoleucyl-L-lysyl-L-valyl-L-tyrosyl-L-prolyl-L-asparaginylglycyl-L-valyl-L-a-glutamyl-L-a-glutamyl-L-a-glutamyl-L-seryl-L-alanyl-L-a-glutamyl-L-seryl-L-tyrosyl-L-prolyl-L-methionyl-L-a-glutamyl-

Corticotropin-likeintermediate lobe peptide (human) (9CI);
a18-39-Corticotropin (pig),31-L-serine-;
10: PN: US20090175821 SEQID: 10 claimed protein;
10: PN:WO0069900 SEQID: 10 unclaimed sequence;
1: PN: WO2009040073 PAGE: 98 claimedprotein;
3: PN: EP1990827 SEQID: 3 unclaimed sequence;
40: PN: WO2006017688SEQID: 40 unclaimed sequence;
5: PN: US20050148098 SEQID: 5 unclaimed sequence;
CLIP (human);
Corticotropin-like intermediate lobe peptide (Macaca nemestrina);
Corticotropin-like intermediate lobe peptide (Mustela vison);
HumanACTH(18-39);
L-Phenylalanine, L-arginyl-L-prolyl-L-valyl-L-lysyl-L-valyl-L-tyrosyl-L-prolyl-L-asparaginylglycyl-L-alanyl-L-a-glutamyl-L-a-aspartyl-L-a-glutamyl-L-seryl-L-alanyl-L-a-glutamyl-L-alanyl-L-phenylalanyl-L-prolyl-L-leucyl-L-a-glutamyl-

Ethanol,2-[[1-methyl-2-[3-(trifluoromethyl)phenyl]ethyl]amino]-, 1-benzoate,hydrochloride (1:1);
Ethanol,2-[[1-methyl-2-[3-(trifluoromethyl)phenyl]ethyl]amino]-, benzoate (ester),hydrochloride (9CI);
Ethanol, 2-[[a-methyl-m-(trifluoromethyl)phenethyl]amino]-, benzoate (ester),hydrochloride (8CI);
(?à)-N-(2-Benzoyloxyethyl)norfenfluramine hydrochloride;
Benfluorexhydrochloride;
JP 992;
mediator;
mediaxal;
S 992

化工产品